ACADIA Pharmaceuticals, Inc. (ACAD)
18.14
-0.23
(-1.25%)
USD |
NASDAQ |
Nov 12, 16:00
18.12
-0.02
(-0.08%)
After-Hours: 20:00
ACADIA Pharmaceuticals Free Cash Flow (Quarterly) : 10.26M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 10.26M |
| June 30, 2026 | 95.69M |
| March 31, 2026 | 28.77M |
| December 31, 2025 | -52.74M |
| September 30, 2025 | 73.90M |
| June 30, 2025 | 63.66M |
| March 31, 2025 | -78.52M |
| December 31, 2024 | 39.93M |
| September 30, 2024 | 63.18M |
| June 30, 2024 | 25.01M |
| March 31, 2024 | 29.08M |
| December 31, 2023 | 85.39M |
| September 30, 2023 | -59.00M |
| June 30, 2023 | -31.80M |
| March 31, 2023 | -17.93M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -0.727M |
| June 30, 2022 | -13.12M |
| March 31, 2022 | -76.33M |
| December 31, 2021 | -23.12M |
| September 30, 2021 | -17.06M |
| June 30, 2021 | -25.37M |
| March 31, 2021 | -61.22M |
| December 31, 2020 | -29.49M |
| September 30, 2020 | -24.51M |
| Date | Value |
|---|---|
| June 30, 2020 | -39.82M |
| March 31, 2020 | -49.94M |
| December 31, 2019 | -29.91M |
| September 30, 2019 | -18.93M |
| June 30, 2019 | -38.42M |
| March 31, 2019 | -65.00M |
| December 31, 2018 | -39.65M |
| September 30, 2018 | -43.30M |
| June 30, 2018 | -40.99M |
| March 31, 2018 | -45.68M |
| December 31, 2017 | -29.90M |
| September 30, 2017 | -58.46M |
| June 30, 2017 | -59.16M |
| March 31, 2017 | -71.05M |
| December 31, 2016 | -63.44M |
| September 30, 2016 | -49.73M |
| June 30, 2016 | -55.32M |
| March 31, 2016 | -41.42M |
| December 31, 2015 | -34.64M |
| September 30, 2015 | -32.04M |
| June 30, 2015 | -30.55M |
| March 31, 2015 | -26.33M |
| December 31, 2014 | -17.90M |
| September 30, 2014 | -17.56M |
| June 30, 2014 | -16.97M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -193.63M |
| Arcturus Therapeutics Holdings, Inc. | -6.114M |
| ADMA Biologics, Inc. | 15.30M |
| Immunic, Inc. | -31.25M |
| Viking Therapeutics, Inc. | -138.19M |